Covid-19 Impact on Biohacking Market Pegged for Robust Expansion by 2028

Stratview Research has published a new report on the Biohacking Market, segmented by Type (Inside, Outside), by Product (Smart Drugs, Sensors, Strains, Others), by Application (Synthetic, Genetic Engineering, Forensic Science, Diagnosis & Treatment, Drug Testing, Others), by End-Use (Pharmaceutical & Biotechnological Companies, Forensic Laboratories, Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World). This report provides critical insights into the market dynamics and enables strategic decision-making for the existing and new market players.

Market Highlights

The biohacking market was estimated at USD 18.2 billion in 2021 and is likely to grow at a CAGR of 18.88% during 2022-2028 to reach USD 61.34 billion in 2028.

What is biohacking?

Biohacking, also known as do-it-yourself (DIY) biology, gives everyone including communities, individuals, research institutes, and small group organizations, the ability to deconstruct and reconstruct biology using simple kits or supplements for the purpose of not only achieving their immediate outcomes as well as contributing to solving larger issues.

Market Dynamics

Growing innovative trends towards neuro-nutrition as well as increasing awareness of biohacking in the health & wellness space are likely to boost the product demand.

• Significant technological growth coupled with the Internet of things (IoT) penetration in consumer electronics and healthcare also augments the industry growth.
• Furthermore, the rising demand for smart drugs and devices to cater to the quality healthcare needs among the population as well as the high prevalence of chronic disorders are further expected to bolster the market expansion.

Segmentation –

This report studies the Biohacking market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:

By type, the biohacking market has been segmented into pharmaceutical & biotechnological companies, forensic laboratories, and others.

• Under these, the pharmaceutical & biotechnological companies segment held a considerable market share in 2021 and is likely to register the fastest CAGR during the review period.
• This is mainly attributed to the increasing geriatric population.
• Also, surging demand for devices for monitoring the heart rate, blood sugar level, and body movement is proliferating segment growth.

By region, the North American market witnessed the highest market share in 2021 and is estimated to grow at a substantial CAGR during the assessment period. This is mainly ascribed to a surge in healthcare expenditure, technologically advanced healthcare infrastructure, and well-established healthcare companies. Moreover, growing healthcare expenditure and improving standards of living with large population growth further boosts regional growth.

About Stratview Research-

Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.

Connect with our team here–
https://www.stratviewresearch.com/contact

Or

Call us @:  +1-313-307-4176

Article source: https://article-realm.com/article/Business/Marketing/46952-Covid-19-Impact-on-Biohacking-Market-Pegged-for-Robust-Expansion-by-2028.html